Insulet (PODD) Interest & Investment Income (2010 - 2026)
Insulet's (PODD) quarterly Interest & Investment Income came in at $4.9 million in Q1 2026, down 52.43% YoY from $10.3 million in Q1 2025, and down 14.04% on a QoQ basis from $5.7 million in Q4 2025.
Insulet (PODD) Interest & Investment Income (2010 - 2026) Analysis & Trends
Insulet (PODD) has 11 years of Interest & Investment Income data on file, last reported at $4.9 million in Q1 2026.
- Quarterly Interest & Investment Income fell 52.43% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.3 million (down 27.48% YoY) and the FY2025 annual result came in at $34.7 million, down 12.15% from the prior year.
- Interest & Investment Income declined to $4.9 million in Q1 2026, from $5.7 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $10.5 million in Q3 2024 to a low of $2.4 million in Q3 2022.
- A 5-year average of $7.7 million and a median of $8.6 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 258.33% — and 2026, when it plunged 52.43%.
- Tracing PODD's Interest & Investment Income over 5 years: stood at $6.0 million in 2022, then advanced by 3.33% to $6.2 million in 2023, then surged by 66.13% to $10.3 million in 2024, then sank by 44.66% to $5.7 million in 2025, then decreased by 14.04% to $4.9 million in 2026.
- The last three Interest & Investment Income figures came in at $4.9 million (Q1 2026), $5.7 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Insulet | 10.37 Bn | 9.84 Bn | 562.60 Mn | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.60 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 5.70 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 10.10 Mn |
| Mar 31, 2025 | 10.30 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 6.20 Mn |
| Sep 30, 2023 | 8.60 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Sep 30, 2015 | 46,000.00 |
| Jun 30, 2015 | 41,000.00 |
| Mar 31, 2015 | 36,000.00 |
| Dec 31, 2014 | 37,000.00 |